Characterization of T-Bet and Eomes in Peripheral Human Immune Cells by James J. Knox et al.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ORIGINAL RESEARCH ARTICLE
published: 14 May 2014
doi: 10.3389/fimmu.2014.00217
Characterization ofT-bet and Eomes in peripheral human
immune cells
James J. Knox 1, Gabriela L. Cosma2, Michael R. Betts1* and Laura M. McLane1*
1 Department of Microbiology, Perelman Institute for Immunology, University of Pennsylvania, Philadelphia, PA, USA
2 Department of Immunology, Thomas Jefferson University, Philadelphia, PA, USA
Edited by:
Bruno Laugel, Cardiff University
School of Medicine, UK
Reviewed by:
David K. Cole, Cardiff University, UK
Michael A. Moody, Duke Human
Vaccine Institute, USA
*Correspondence:
Michael R. Betts and Laura M.
McLane, Department of Microbiology,
Perelman Institute for Immunology,
University of Pennsylvania, 3610
HamiltonWalk, 406 Johnson Pavilion,
Philadelphia, PA 19104, USA
e-mail: betts@mail.med.upenn.edu;
lmclane@mail.med.upenn.edu
The T-box transcription factors T-bet and Eomesodermin (Eomes) have been well defined
as key drivers of immune cell development and cytolytic function. While the majority of
studies have defined the roles of these factors in the context of murine T-cells, recent
results have revealed that T-bet, and possibly Eomes, are expressed in other immune cell
subsets. To date, the expression patterns of these factors in subsets of human peripheral
blood mononuclear cells beyondT-cells remain relatively uncharacterized. In this study, we
used multiparametric flow cytometry to characterize T-bet and Eomes expression in major
human blood cell subsets, including total CD4+ and CD8+ T-cells, γδ T-cells, invariant NKT
cells, natural killer cells, B-cells, and dendritic cells. Our studies identified novel cell sub-
sets that expressT-bet and Eomes and raise implications for their possible functions in the
context of other human immune cell subsets besides their well-known roles in T-cells.
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INTRODUCTION
The transcription factors T-bet (T-box expressed in T-cells) and
Eomesodermin (Eomes) belong to the phylogenetically related
family of T-box transcription factors that share a sequence-
specific T-box DNA-binding domain first identified in the murine
Brachyury gene (1). While members of this family are known to
play diverse roles in various developmental processes (2, 3), the
functions of T-bet and Eomes have been best described in the
context of the mouse immune system.
T-bet was originally defined as the master regulatory transcrip-
tion factor involved in promoting TH1 CD4+ T-cell development
while specifically inhibiting TH2 and TH17 lineage-defining pro-
grams in murine models (4–7). T-bet is known to modulate a
number of genes involved in T-cell mobilization (CXCR3), cell
signaling (IL12Rβ1), and cytolytic signaling molecules (IFNγ)
(8). Additionally, high levels of T-bet expression are closely asso-
ciated with cytotoxic CD8+ T-cell effector differentiation and
function, including the upregulation of perforin and granzyme
B in antigen-specific cells (9–12). T-bet has been implicated in
sustaining memory subsets (13–16), however, T-bet levels decline
as cells become more memory-like (17).
Eomesodermin was originally identified in Xenopus (18), and
has since been found in many other vertebrates, where it plays
key roles in mesoderm formation and early gastrulation events
(18, 19). In the immune system, like T-bet, Eomes can positively
influence the expression of IFNγ in CD8+ T-cells (13, 20, 21).
In contrast to T-bet, Eomes expression increases as cells become
more memory-like (10, 14, 16, 17) and Eomes knockout mice
are deficient in long-term memory formation and fail to undergo
homeostatic renewal (14, 16, 22) highlighting its critical role for
memory differentiation.
Recently, evidence has emerged in mice that T-bet and Eomes
may function in the context of other cells of the immune system;
however, few studies have described the expression of these factors
in human non-thymocyte immune cells. Additionally, few studies
have investigated the co-expression of these factors within dif-
ferent immune cell subsets. In this study, we sought to broadly
characterize the resting expression patterns of T-bet and Eomes
in the context of a number of immune cells from normal human
donors and to provide direct comparative data with identical opti-
mal experimental conditions and cell sources to serve as a reference
for future studies on these transcription factors in human lympho-
cytes. Using multiparametric flow cytometry, our results reveal
some parallels between human and mouse models, however, we
find key differences in specific cell subsets suggesting the role of
these factors might not be identical in mouse and humans. Taken
together, these studies suggest roles for these factors, both inde-
pendently and together, beyond their known functions in CD4+
and CD8+ T-cells.
MATERIALS AND METHODS
HUMAN CELLS
Donor peripheral blood mononuclear cells (PBMCs) were col-
lected after written, informed consent from the University of
Pennsylvania’s Center for AIDS Research Human Immunology
Core (IRB #705906) in compliance with IRB guidelines. PBMCs
were cryopreserved in fetal bovine serum (FBS; Hyclone) contain-
ing 10% dimethyl sulfoxide (DMSO; Fisher Scientific) and stored
at−140°C until further use.
FLOW CYTOMETRY ANALYSIS
Flow cytometry analysis was performed as previously described
(10) using PBMCs from at least eight normal donors. Where
appropriate, statistical analyses were performed using Graph-
Pad Prism software (Version 5.0a). For these studies, non-
parametric Wilcoxon matched paired t tests were used where
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Gaussian distribution is not assumed because we analyzed <25
subjects.
To identify CD4+, CD8+, and T-regulatory (Treg) T-cells,
the following antibodies were used: α–CD3-BV570 (Biolegend),
α–CD4-PE Cy5.5 (Invitrogen), α–CD8-BV605 (Biolegend), α–
CD14/α–CD16/α–CD19-APC Cy7 (BD Bioscience), α–CCR7-
BV711 (Biolegend), α–CD45RO-PE Texas Red (Beckman Coul-
ter), α–CD27-FITC (eBioscience), α–CD25-PE Cy5 (Invitrogen),
α–CD127-PE Cy7 (eBioscience), α–T-bet-PE (eBioscience), α–
Eomes-Alexa647 (eBioscience), and α–Foxp3 Alexa700 (eBio-
science).
To identify natural killer (NK), invariant natural killer
(iNKT), and γδ T-cells, the following antibodies were used:
α–CD3-BV570 (Biolegend), α–CD4-PE Cy5.5 (Invitrogen), α–
CD8-BV605 (Biolegend), α–CD16-PE Cy5 (Biolegend), α–CD56-
Alexa700 (Biolegend), α–CD19-BV785 (Biolegend), α–CD45RO-
PE Texas Red (Beckman Coulter), α–γδ TCR-FITC (Biolegend),
α–Vα24Jα18-PE Cy7 (Biolegend), α–T-bet-PE (eBioscience), and
α–Eomes-eF660 (eBioscience).
To identify B-cell subsets, the following antibodies were used:
α–CD3-BV570 (Biolegend),α–CD14/α–CD16-APC Cy7 (BD Bio-
science), α–CD19-BV785 (Biolegend), α–CD20-PE Texas Red
(BD Bioscience),α–IgD-Alexa700 (BD Bioscience),α–IgM-BV605
(Biolegend), α–CD38-BV421 (Biolegend), α–CD10-PE Cy5 (BD
Bioscience),α–CD21-PE Cy7 (Biolegend),α–CD27-BV650 (Biole-
gend), α–IgG1-Alexa488 (Invitrogen), α–T-bet-PE (eBioscience),
and α–Eomes-eF660 (eBioscience).
In addition to previously mentioned antibodies, the follow-
ing were used to identify dendritic cell subsets: α–CD14-QD655
(Invitrogen), α–CD11c-FITC (BD Bioscience), α–HLADR-V450
(BC Bioscience), α–CD56-PE Texas Red (Invitrogen), and α–
CD123 PE Cy5 (Biolegend).
RESULTS
T-bethi AND EOMES EXPRESSION CORRELATES WITH TEM AND
EFFECTOR CD8+ T-CELLS
T-bet and Eomes have been extensively studied in murine CD8+
T-cells and are critical for effector function and long-term mem-
ory formation, respectively (13, 20, 23–25). Recently, we described
T-bet and/or Eomes in human CD8+ T-cell memory populations
using various combinations of the memory markers CD27, CCR7,
and CD45RO (9, 10, 26). While a fair amount is known about the
relationship between T-bet and Eomes and the individual memory
markers, the breakdown of their combined expression is not well
defined.
Based upon coordinate expression of CD27, CD45RO, and
CCR7, we delineated peripheral blood CD8+ T-cells into six dif-
ferent populations, including naïve (CCR7+CD45RO−CD27+),
central memory (TCM, CCR7+CD45RO+CD27+), transitional
memory (CCR7−CD45RO+CD27+), effector memory (TEM,
CCR7−CD45RO+CD27−), intermediate (CCR7−CD45RO−CD27+),
and effector (CCR7−CD45RO−CD27−) CD8+ T-cells using a
Boolean gating strategy (Figure 1A; Figure S1 in Supplementary
Material). For simplicity, we focused on naïve, central memory,
effector memory, and effector populations in Figure 1 (refer to
Figures S1A–D in Supplementary Material for the more detailed
breakdown of these populations). Representative gating for T-bet
and Eomes expression within effector CD8+ T-cells from a nor-
mal human donor is shown in Figure 1A. As has been previously
reported (10, 23, 26), T-bet has a graded expression pattern includ-
ing distinct T-bethi and T-betlo populations (Figure 1A, right
panel). Approximately 60% of total CD8 T-cells expressed T-bet
(Figure 1B). While less than 20% of naïve CD8+ T-cells were T-
bet+, significantly more TCM, TEM, and effector T-cells expressed
T-bet (Figure 1B, data not shown). As shown previously (10, 26),
the majority of T-bet+ cells within memory CD8+ T-cell pop-
ulations were T-betlo; however, as cells progress toward a more
terminally differentiated phenotype, the frequency of T-bethi cells
significantly increased (Figure 1C). Taken together, these data sug-
gest that high levels of T-bet are likely crucial for function in
effector and some effector memory CD8+ T-cells, whereas T-bet
may play a less definitive role in naïve and TCM differentiation and
function.
We next investigated Eomes expression within memory CD8+
T-cell memory subsets. Less than half of total CD8+ T-cells
expressed Eomes (Figure 1D). Like T-bet, Eomes is expressed
most infrequently in naïve CD8+ T-cells. While the frequency
of Eomes+ TCM, TEM, and effector CD8+ T-cells increased sig-
nificantly compared to naïve T-cells (data not shown), we found
no significant difference in the frequency of TCM T-bet+ cells
compared to TEM or effector cells. Additionally, there is more
Eomes per cell in memory CD8+ T-cells compared to naïve T-
cells (when it is expressed) as measured by median fluorescence
intensity (MFI) analysis (Figure 1E). Taken together, these data
indicate that Eomes is expressed in the highest frequency in effec-
tor cells but, on average, these cells do not express more Eomes per
cell compared to other CD8+ T-cell memory subsets.
Because T-bet and Eomes likely have both redundant and
unique roles in CD8+ T-cells (20, 27), we next investigated
the co-expression of these factors in the CD8+ T-cell memory
populations (Figure 1F). Naïve cells were almost exclusively T-
bet−Eomes− (Figure 1F, black bars). TCM CD8+ T-cells were
mainly T-betlo Eomes+/−, or T-bet− Eomes− (dark gray bars).
Like TCM, TEM T-cells were mainly T-betlo Eomes+/−; however,
TEM had a significantly higher frequency of T-bethi Eomes+ com-
pared to TCM. Further, effector CD8+ T-cells had the highest
frequency of T-bethi Eomes+ CD8+ T-cells. Interestingly, T-bethi
TEM and effector CD8+ T-cells were almost exclusively Eomes+
suggesting high levels of T-bet correlate with Eomes expres-
sion and these factors could be cooperating to promote critical
functions in these CD8+ T-cell subpopulations.
T-bet AND EOMES ASSOCIATE WITH TEM AND EFFECTOR CD4+ T-CELL
POPULATIONS
Initial work in mouse CD4+ T-cells first defined T-bet as the
master regulator of TH1 development, with direct regulation of
TH1-specific genes such as IFNγ (4). Early reports demonstrated
expression of T-bet also within human CD4+ T-cells, but the pat-
terns of T-bet expression within CD4+ T-cell memory subsets
have remained unclear. We therefore sought to characterize T-bet
expression in human CD4+memory T-cell subsets. As with CD8+
T-cells, memory subpopulations were defined using the markers
CD27, CD45RO, and CCR7 (Figure 2; Figures S1E–H in Supple-
mentary Material). Representative flow plots for effector CD4+
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FIGURE 1 |T-bet and Eomes expression correlates withTEM and
effector CD8+ T-cells. (A) Gating strategy for identifying CD8+ T-cell
subsets. Flow cytometry data shown were gated as follows: singlets,
lymphocytes, Aqua Blue− (live cells), CD14−CD16−CD19−, CD3+, CD4−,
CD8+. Boolean gating of CD27, CCR7, and CD45RO was used to define
CD8+ subsets from eight normal donors. Effector CD8+ T-cells from a
representative donor are shown. (B) The frequency of T-bet+ CD8+ T-cells
within naïve (CCR7+CD45RO−CD27+), TCM (CCR7+CD45RO+CD27+), TEM
(CCR7−CD45RO+CD27−), and effector (CD27−CD45RO−CCR7−) cells is
shown. Each symbol represents an individual donor. (C) Graphical
representation of the mean frequency of T-bethi (gray) and T-betlo (white)
CD8+ T-cells is shown for each memory subset. The box and whisker
graphs display 25–75% (box) and 10–90% (whisker). The line in the box
represents the median value. (D) The frequency of CD8+ T-cells
expressing Eomes is shown for each subset. (E) Median fluorescence
intensity (MFI) is shown for Eomes within each subpopulation.
(F) Co-expression of T-bet and Eomes within each memory subset is
shown. *p<0.04, **p<0.004.
T-cells are shown in Figure 2A. Overall, within our cohort, ~25%
of total CD4+ T-cells expressed T-bet (Figure 2B). Few naïve
human CD4+ T-cells were T-bet+, with a significant majority of
T-bet expression found within the non-naïve CD4+ T-cell popu-
lation (Figure 2B, data not shown). Approximately 20% of TCM
CD4+ T-cells expressed T-bet and that T-bet is almost exclusively
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FIGURE 2 |T-bet and Eomes expression associates withTEM and
effector CD4+ T-cell populations. (A) Gating strategy for identifying
CD4+ T-cell subsets. Flow cytometry data shown were gated as follows:
singlets, lymphocytes, Aqua Blue− (live cells), CD14−CD16−CD19−, CD3+,
CD8−, CD4+. Boolean gating of CD27, CCR7, and CD45RO was used to
define CD4+ subsets from eight normal donors. Effector CD4+ T-cells
from a representative donor are shown. (B) The frequency of T-bet+ CD4+
T-cells within naïve (CCR7+CD45RO−CD27+), TCM (CCR7+CD45RO
+CD27+), TEM (CCR7−CD45RO+CD27−), and effector
(CD27−CD45RO−CCR7−) cells is shown. Each symbol represents an
individual donor. (C) Graphical representation of the mean frequency of
T-bethi (gray) and T-betlo (white) CD4+ T-cells is shown for each subset. The
box and whisker graphs display 25–75% (box) and 10–90% (whisker). The
line in the box represents the median value. (D) The frequency of CD4+
T-cells expressing Eomes is shown for each subset. (E) Median
fluorescence intensity (MFI) is shown for Eomes within each
subpopulation. (F) Co-expression of T-bet and Eomes within each
memory subset is shown. *p<0.04, **p<0.004.
T-betlo (Figures 2B,C). Significantly more TEM and effector CD4+
T-cells expressed T-bet compared to TCM, however there was no
difference between TEM and effector CD4+ T-cells. While TEM
cells had the highest frequency of T-betlo cells, the frequency of T-
bethi CD4+ T-cells increased significantly as cells progress toward
a more effector-like phenotype suggesting that T-bet is likely more
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critical to the functions of CD4+ TEM and effector cells than TCM
function.
Like T-bet, Eomes also plays a role in murine CD4+ T-cell dif-
ferentiation. Eomes can induce both TH1 differentiation as well
as expression of IFNγ and perforin in mouse CD4+ T-cells (13,
20, 21, 28). Eomes can also compensate for the loss of T-bet in
CD4+ effector T-cells and drive polyfunctionality in human CD4+
T-cells (29); however, there are few ex vivo studies addressing
Eomes expression in human CD4+ T-cells. In contrast to T-bet,
very few human peripheral blood CD4+ T-cells express Eomes
(Figure 2D). As cells become more effector-like, the frequency of
Eomes+ cells significantly increases however the frequency only
reaches ~25% in effector cells. Compared to naïve cells, we found
a significantly higher Eomes MFI within each Eomes+ memory
CD4+ T-cell subpopulation; however, while there was a trend
toward higher Eomes MFI as cells become more effector-like, these
differences were not significant (Figure 2E).
Because both T-bet and Eomes are known to induce IFNγ
expression and multiple cytolytic functions in CD4+ T-cells (13,
20, 21, 30), we next examined co-expression of these factors within
CD4+ T-cell subsets. We found significant increases in the fre-
quency of all Eomes+ populations regardless of T-bet levels as
cells progress to being more effector-like (Figure 2F). Like CD8+
T-cells, there were very few T-bethi cells that did not express Eomes,
suggesting that high levels of these factors could cooperate to drive
TEM and effector differentiation and function; however, in con-
trast to murine studies, the majority of resting CD4+ T-cells were
either T-bet− Eomes− or T-betlo Eomes− suggesting that, at least
in the context of resting peripheral blood CD4+ T-cells, T-bet, and
Eomes may not contribute to resting CD4+ T-cell function.
CD4+ T-REGULATORY CELLS EXPRESS LOW LEVELS OF T-bet
T-regulatory cells function to suppress immune responses from
other cell types to prevent hyperactivity or autoimmune disease.
Treg cells have been reported to upregulate T-bet in vivo dur-
ing type-1 inflammatory responses (31); however, little is known
about T-bet in circulating human Treg cells. We next character-
ized T-bet and Eomes expression in resting CD8+ and CD4+ Treg
cells. We identified Treg cells within both CD8+ and CD4+ pop-
ulations using the markers CD25 and FoxP3 (Figure 3A). Only
a small fraction of CD8+ T-cells were CD25+ Foxp3+, whereas
CD4+ CD25+ Foxp3+ cells comprise about 1.5% of total PBMCs
(Figure 3B). Within each of these Treg populations, ~8% of cells
expressed T-bet (Figure 3C) and this T-bet was almost exclusively
T-betlo (Figure 3D). Eomes expression was not detected in cir-
culating Treg cells (data not shown). Taken together, these data
indicate that neither T-bet nor Eomes likely contribute to resting
human Treg function.
CD127 EXPRESSION INVERSELY CORRELATES WITH T-bet EXPRESSION
IN CD8+ T-CELLS
We next investigated the relationship between long-term memory
formation and expression of T-bet and Eomes in CD8+ and CD4+
T-cells through examination of IL-7 receptor (CD127) expression.
T-cells are dependent upon IL-7 signaling for survival (32–36).
In mice, naïve T-cells express CD127 and following T-cell recep-
tor stimulation, CD127 is downregulated (32, 33, 37–39). Recent
studies have suggested that the upregulation of T-bet in CD8+
T-cells results in the downregulation of CD127 (14, 23); how-
ever, a study in Leishmania-specific CD4+ T-cells suggest that
the expression of T-bet did not inhibit CD127 expression, nor
FIGURE 3 | Resting CD4+ Treg cells express low levels ofT-bet. (A) Gating
strategy for identifying CD4+ and CD8+ Treg T-cells. Flow cytometry data
shown were gated as follows: singlets, lymphocytes, Aqua Blue− (live cells),
CD14−CD16−CD19−, CD3+, CD8+ or CD4+, and CD25+ FoxP3+. A
representative donor is shown. (B) The frequency of CD8+ and CD4+ Treg
T-cells is shown. (C) The frequency of T-bet+ CD8+ and CD4+ Treg T-cells is
shown. (D) Graphical representation of the mean frequency of T-bethi (gray)
and T-betlo (white) CD8+ and CD4+ Treg T-cells is shown. The box and whisker
graphs display 25–75% (box) and 10–90% (whisker). The line in the box
represents the median value. *p<0.04, **p<0.004.
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did the loss of T-bet result in upregulation of CD127 (40). Based
on these results, we examined the relationship between T-bet and
Eomes expression with CD127 in the context of human CD8+ and
CD4+ T-cells. Correlating with previously published data (41, 42),
CD127 was expressed in upwards of 85% of both CD8+ and CD4+
T-cells and the frequency of cells expressing CD127 decreased as
cells became more effector-like (data not shown). Representative
flow plots displaying the relationship between T-bet or Eomes
and CD127 from one normal donor are shown in Figure 4A. In
CD4+ T-cells, CD127 was expressed regardless of the presence or
absence of T-bet or Eomes (Figure 4B, white bars). In contrast,
as T-bet or Eomes expression increased in memory CD8+ T-cells,
the frequency of CD127+ cells significantly decreased compared
to CD4+ T-cells (Figure 4B, black bars). These results suggest that
T-bet and Eomes may play a different role in controlling CD127
expression in CD8+ T-cells compared to CD4+ T-cells.
T-bet AND EOMES ARE CO-EXPRESSED IN HUMAN γδ T-CELL SUBSETS
AND CD4−CD8− iNKT CELLS
γδ T-cells and invariant natural killer T-cells (iNKT cells) are
innate-like T-cell family members expressing T-cell receptors with
restricted antigen recognition potential compared to classical αβ
T-cells (43, 44). T-bet mRNA and protein, as well as Eomes mRNA,
are detectable in mouse γδ T-cells, where it is suggested that they
cooperate to control IFNγ production (45, 46). In mouse iNKT
cells, T-bet is required for iNKT developmental progression and
the acquisition of effector functions (21, 47). Expression of these
transcription factors has not been comprehensively demonstrated
in human γδT and iNKT cells; therefore, we sought to characterize
T-bet and Eomes expression in human γδ T and iNKT cells. We
defined γδ T-cells as γδ TCR+ within CD3+CD4−CD8− PBMCs
(Figure 5A); iNKT cells were identified within CD3+ PBMCs
as TCR Vα24Jα18+ (Figure 5B). We further subdivided iNKT
cells into CD4−CD8− and CD4+ subgroups, the best described
subpopulations of human iNKT cells (43). While we could detect
CD4−CD8+ iNKT cells, they were infrequent and only detectable
in 4/8 donors (data not shown).
As found in mice (21, 45–47), we observed T-bet expres-
sion in both resting γδ T and the major subsets of iNKT cells
(Figure 5C). Approximately 60% of γδ T-cells and 50% of iNKT
cells expressed T-bet, although we found considerable variation
between donors within the iNKT population (Figures 5C,D, white
bars). After subdividing iNKT cells into CD4−CD8− and CD4+
subsets, we found that the frequency of T-bet-expressing cells was
significantly higher in the CD4−CD8− population compared to
the CD4+ subset (Figure 5C). Additionally, significantly more
CD4−CD8− iNKT cells were T-bethi compared to the CD4+
population (Figure 5D, gray bars). These findings indicate that
CD4−CD8− iNKT cells generally express T-bet, while CD4+
iNKT cells express T-bet at lower, more variable levels, suggest-
ing that T-bet plays a particularly important role in the function
of CD4−CD8− iNKT cells.
Eomesodermin was detectable in ~40% of γδ T-cells. In con-
trast to previous murine studies that were unable to detect Eomes
mRNA (21), we found that ~30% of human iNKT cells expressed
Eomes protein, although there was significant variation between
subjects (Figure 5E). CD4−CD8− iNKT cells account for the
majority of Eomes expression within the total iNKT-cell pop-
ulation, as a significantly higher frequency of CD4−CD8− cells
expressed Eomes compared to CD4+ iNKT cells (Figure 5E).
Despite differences in the frequency of Eomes+ cells between iNKT
subsets, both subgroups expressed similar levels of Eomes on a
per cell basis (Figure 5F). Taken together, these data indicate that
Eomes is differentially expressed in human iNKT cells compared
to murine iNKT cells and suggest a role for Eomes in the context
of human iNKT cells.
In both total γδ T-cells and total iNKT cells, the majority
of Eomes+ cells co-expressed T-bet, whereas Eomes− cells were
FIGURE 4 | CD127 expression inversely correlates withT-bet
expression in CD8+ T-cells. (A) Gating strategy for identifying CD8+
or CD4+ CD127+ T-cell memory subsets. Flow cytometry data
shown were gated as follows: singlets, lymphocytes, Aqua Blue−
(live cells), CD14−CD16−CD19−, CD3+, CD8+ or CD4+, CD127+. A
representative donor is shown. (B) The frequency of CD127+ CD8+
(black), or CD4+ (white) T-cells expressing T-bet or Eomes is shown.
**p<0.004.
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FIGURE 5 | Co-expression ofT-bet and Eomes in γδT-cells and CD4−CD8−
iNKT cells. (A,B) Gating strategies for identifying (A) γδT-cells and (B) iNKT
cells. γδT-cells and iNKT cells were gated as follows: singlets, lymphocytes,
Aqua Blue− (live cells), CD14−CD16−CD19−, CD3+, γδTCR+ (γδT-cells) or
Vα24αJα18+ (iNKT cells). T-bet and Eomes expression within these cells from
a representative donor is shown. (C) The frequency of T-bet expression in total
γδT-cells and iNKT cells is shown. Each symbol represents an individual
donor. (D) Graphical representation of the mean frequency of T-bethi (gray) and
T-betlo (white) expression in these populations is shown. The box and whisker
graphs display 25–75% (box), 10–90% (whisker), and the median value (line).
(E) The frequency of Eomes+ γδ and iNKT cells is shown for each cell subset.
(F) Median fluorescence intensity (MFI) is shown for Eomes+ cells within
each cell subset. (G) The frequency of T-bet and Eomes co-expression within
each cell population is shown. *p<0.04.
either T-betlo or T-bet− (Figure 5G). Greater than 60% of CD4+
iNKT cells did not express T-bet or Eomes, and the remainder
were T-betlo Eomes−. CD4−CD8− iNKT cells contained substan-
tial T-bethi Eomes+ and T-betlo Eomes+ populations, both of
which occurred at a significantly higher frequency than in CD4+
iNKT cells. These findings indicate that T-bet and Eomes are
highly co-expressed in the CD4−CD8−, but not in CD4+ iNKT
cells, suggesting T-bet and Eomes could cooperatively function in
CD4−CD8− NKT cells.
T-bet AND EOMES ARE HIGHLY EXPRESSED IN HUMAN NATURAL
KILLER CELLS
In mice, T-bet and Eomes modulate many NK cell effector func-
tions, including cytotoxicity and cytokine production (21, 48).
Additionally, their expression is crucial for murine NK devel-
opmental regulation where they cooperate to influence several
key developmental checkpoints (49). T-bet and Eomes have
been highly studied in mouse models, but there are few studies
investigating the expression patterns of T-bet and Eomes within
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FIGURE 6 | DistinctT-bet and Eomes expression patterns between
CD56bright and CD56dim NK cells. (A) Gating strategy for identifying NK
cell subsets. NK subpopulations were gated as follows: singlets,
lymphocytes, Aqua Blue− (live cells), and CD14−CD19−CD3−. Mature NK
cell populations, CD56bright (CD56hi CD16−) and CD56dim (CD56lo CD16+),
from a representative donor are gated. T-bet and Eomes expression in
CD56bright cells (red) and CD56dim cells (blue) are plotted. (B) The
frequency of T-bet expression in CD56bright and CD56dim NK cells is
shown. Each symbol represents and individual donor. (C) Box and
whisker graphical representation of the frequency of T-bethi (gray) and
T-betlo (white) expression for each NK population is shown. The box and
whisker graphs display 25–75% (box), 10–90% (whisker), and the
median value (line). (D) The frequency of Eomes-expressing NK cells is
shown. (E) Eomes MFI from Eomes+ cells from each NK population is
shown. (F) Frequency of T-bet and Eomes co-expression within each
subset. *p<0.04.
human NK cell populations; therefore, we next assessed T-bet
and Eomes in human NK subsets. We identified two mature
NK cell populations within CD14−CD19−CD3− PBMCs based
upon CD56 and CD16 expression (Figure 6A), here referred to as
CD56bright (CD56hi CD16−) and CD56dim (CD56lo CD16+) cells.
We observed a gradient of T-bet expression with the CD56bright
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population (Figure 6A, right panel). While virtually all mature NK
cells expressed T-bet, both the frequency of T-bet+ cells and the
amount of T-bet per cell was significantly greater in the CD56dim
population compared to the CD56bright population (Figures 6B,C,
gray bars). Conversely, the T-betlo population was significantly
larger in CD56bright cells (white bars). Taken together, these data
suggest that there may be an association between T-bet expres-
sion levels and functional capacity in NK cells: CD56dim NK cells
highly express T-bet and are highly cytotoxic, while poorly cyto-
toxic CD56bright NK cells express less T-bet and function mainly
to produce cytokines (50).
While Eomes was expressed in both CD56bright and CD56dim
NK cells, a significantly higher frequency of CD56bright cells were
Eomes+ compared to CD56dim cells (Figure 6D). Additionally,
Eomes+ CD56bright cells expressed significantly more Eomes on a
per cell basis than Eomes+ CD56dim cells (Figure 6E), suggesting
that Eomes is likely crucial for CD56bright function.
We next investigated the co-expression of T-bet and Eomes
within the CD56dim and CD56bright NK populations. The majority
of both NK cell subpopulations were T-bethi Eomes+ (Figure 6F);
however, in the remaining cells we found unique co-expression
patterns of these transcription factors between the NK subsets.
Approximately 15% of CD56bright NK cells were T-betlo Eomes+,
and this subpopulation was virtually non-existent in the CD56dim
cells. Conversely, ~35% of CD56dim NK cells were T-bethi Eomes−,
compared to CD56bright cells which did not have this population.
Taken together, these results suggest that while T-bet and Eomes
likely play complementary or cooperative roles in the majority of
NK cells, there may be distinct subpopulations of NK cells where
T-bet and Eomes differentially regulate NK cell function.
T-bet IS PREDOMINANTLY EXPRESSED IN MATURE HUMAN B-CELL
PLASMABLASTS
Murine studies have revealed that T-bet is expressed in lymphoid
tissue B-cells, where it regulates functional processes such as class
switching (51, 52) and homing (53). A recent study of T-bet in B-
cells revealed that T-bet is initially expressed during the primary
immune response and expression is maintained in IgG2a+ mem-
ory B-cells, where it is necessary for cell survival and secondary
immune responses (54). Additionally, there is evidence to suggest
that expression of T-bet in B-cells is necessary for clearance of
gHV68, a murine herpes virus (55). While it is appreciated that
T-bet is necessary for appropriate B-cell function and antibody
responses in mice, T-bet expression is not well-characterized in
human B-cells.
To identify B-cell subpopulations, CD19+ PBMCs were phe-
notyped using several B-cell markers: IgD, CD10, CD38, and
CD27 (Figure S2 in Supplementary Material). Our analysis focused
specifically on transitional/immature B-cells (IgD+CD10+
CD38+CD27−), naïve B-cells (IgD+CD10−CD38+/−CD27−),
memory B-cells (IgD−CD10−CD38lo/−), and plasmablasts
(IgD−CD10−CD38hiCD27+). Representative flow plots of T-bet
expression (contour plot) within each subpopulation are shown
in Figure 7A. While Eomes was undetectable in B-cells (data
not shown), we found T-bet in ~15% of B-cells (Figure 7B).
This T-bet expression was largely relegated to memory B-cells
and plasmablasts, with significantly lower amounts observed in
transitional/immature and naïve B-cells (Figure 7B). Greater
than 40% of plasmablasts expressed T-bet, a significantly higher
frequency than that of all other B-cell populations, suggesting
that T-bet may play a particularly important role in plasmablast
function.
We next compared T-bet expression levels within different
B-cell populations to other known T-bet-expressing cell types.
Plasmablasts expressed the highest amount of T-bet within the
B-cell subsets (Figure 7C, shaded gray), while naïve B-cells dis-
played the lowest T-bet levels (thick black line). Memory B-cells
(thin black line) generally expressed intermediate levels of T-bet;
however, a small fraction expressed higher T-bet levels compared
to plasmablasts. T-bet expression in T-bet+ B-cells was rela-
tively low compared to other T-bet+ cells, including CD56dim NK
cells (shaded black), representing some of the brightest T-bet-
expressing cells, and CD56bright NK cells (thin gray line), which
express lower levels of T-bet compared to CD56dim cells. Taken
together, these data suggest a key role for T-bet in plasmablasts and
memory B-cell subsets and further indicate that T-bet is expressed
at a lower level in B-cells compared to other T-bet+ lymphocytes.
HUMAN DENDRITIC CELLS DO NOT EXPRESS DETECTABLE T-bet OR
EOMES
Previous studies have shown that several non-lymphocyte pop-
ulations, including myeloid dendritic cells (mDCs) and plas-
macytoid dendritic cells (pDCs), can express T-bet transcript
following IFNγ stimulation (56–58); however, it is unclear
if human resting cells can also express T-bet. Additionally,
Eomes has not been investigated in the context of these pop-
ulations in humans. To characterize the expression of T-bet
and Eomes in resting human dendritic cell populations, we
defined mDCs as CD3−CD14−CD19−CD11c+ and pDCs as
CD3−CD14−CD19−CD123+CD11c−. Neither T-bet nor Eomes
protein was detectable in circulating dendritic cell populations
(data not shown), suggesting that T-bet may be upregulated only
under specific conditions.
DISCUSSION
In recent years, many studies have contributed to defining the
mechanisms of the transcription factors T-bet and/or Eomes in
controlling CD8+ and CD4+ T-cell functions in mice (25, 59–61);
however, studies of T-bet and Eomes in the context of human T-
cells, as well as in other cells of the human immune system, have
been relatively limited. In this study, we characterized the resting
expression patterns of the T-box transcription factors T-bet and
Eomes in various resting peripheral blood immune cell popula-
tions to provide a basic platform for future studies dissecting their
functions within these cell subsets.
Similar to studies in mouse lymphocyte populations, T-bet
expression increases as peripheral cells become more differenti-
ated (effector CD8+ and CD4+ T-cells, CD4−CD8− iNKT cells,
CD56dim NK cells, and memory and plasmablast B-cells). Overall
the same relationship holds true for Eomes expression in these
populations, with the exception of B-cells, which lack Eomes, and
NK cells where the more differentiated CD56 dim cells contain less
Eomes than their predecessor CD56bright cells. Taken together, our
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FIGURE 7 |T-bet expression in antigen-experienced B-cells. (A)T-bet gating
strategy for B-cell populations is shown. Transitional, naïve, memory B-cells,
and plasmablasts populations are depicted as a contour plot overlaying a
density plot of total B-cells. T-bet+ events are gated from a representative
donor. (B) The frequency of T-bet+ B-cells within B-cell subpopulations is
shown. Each symbol represents an individual subject. Statistical differences
of interest, as measured using non-parametric Wilcoxon matched, paired
two-tailed t tests, are described in the text. *p<0.04. (C) Histograms
depicting T-bet expression levels in B-cells and NK cells from a representative
donor. Histograms represent the following subsets: naïve B-cells (thick black
line), memory B-cells (thin black line), plasmablasts (shaded gray), CD56bright
NK cells (gray line), and CD56dim NK cells (shaded black).
data suggest an essential role for T-bet and Eomes during periph-
eral terminal and, in some instances, memory cell differentiation.
Additionally, our data would suggest that loss of T-bet or Eomes,
depending on cell context, during activation of a number of differ-
ent cell types would greatly diminish cell differentiation capacity
and acquisition of terminal effector functions. In HIV, for exam-
ple, chronic HIV progressors display significantly lower levels of
T-bet and its downstream cytotoxic gene target, perforin, within
effector CD8 T-cells compared to elite controller counterparts (9)
suggesting that if T-bet levels could be increased in these cells,
effector function might be restored.
Because T-bet and Eomes are members of the same family of
transcription factors and because they are both associated with
effector memory differentiation, they have proposed redundant
roles in specific cell types. However, our co-expression analysis
reveal that this may not always be the case, and these factors might
indeed have unique roles in the context of specific human cell
subsets.
Co-expression analysis of T-bet and Eomes indicated that in
both CD8+ and CD4+ T-cells, T-bethi TEM and effector cells are
almost exclusively Eomes+ suggesting these two factors cooperate
in the context of these subsets. While T-bethi populations domi-
nate CD8+ TEM and effector cells, CD4+ T-cells are predominantly
T-betlo/− Eomes−, suggesting that in peripheral blood CD4+ T-
cells T-bet and Eomes likely do not significantly cooperate to
modulate CD4+ T-cell function. This observation is in contrast
to what has been shown previously in mouse studies, although
the majority of these studies investigated T-bet and Eomes in the
context of splenic CD4+ cells (62–65). As T-bet has been shown
to control trafficking of lymphocytes through the regulation of
chemokine receptor expression (31, 66) it is possible that T-bet+
Eomes+ CD4+ T-cells do not remain in the blood in humans
and possibly even in mice, thus explaining the low frequency of
co-expressing peripheral CD4+ T-cells.
Similar to CD4+ and CD8+ αβ T-cells, we found that T-bet
and Eomes are expressed in a significant subset of the human γδ
T-cell population. Previous studies have also observed T-bet and
Eomes within mouse γδ T-cells and have linked T-bet and Eomes
expression in these cells to IFNγ production (45, 46). Here, we
also show that human γδ T-cells co-express T-bet and Eomes and,
taken together with mouse studies, these findings suggest that T-
bet and Eomes likely also contribute toward IFNγ production and
other functions in human cells. Most mouse γδ T-cells consti-
tutively express Eomes and can express T-bet upon stimulation
(45, 46), and while a substantial population of human γδ T-cells
co-express these factors, a considerable proportion (~50%) of γδ
T-cells are T-betlo/− Eomes−. This subset may represent naïve γδ
T-cells, which in mice do not express T-bet protein (45), or also
may include subsets of γδ T-cells that do not produce IFNγ, such
as the IL-17-producing cells in human peripheral blood (67).
Co-expression analysis in NK cell subsets would suggest that as
immature NK cells mature into CD56bright cells, Eomes is upregu-
lated and these cells shift from T-betlo Eomes+ to T-bethi Eomes+
CD56bright NK cells. Following appropriate stimuli, CD56bright
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cells develop into T-bethi Eomes+ CD56dim cells and may grad-
ually lose Eomes expression. Murine studies of transcriptional
control support this NK cell maturation model, as Eomes is nec-
essary for the generation and maintenance of mature NK cells
(49) and T-bet is necessary to attain the most terminal stages
of maturation (21, 49). Alternatively, at least a portion of the
T-bethi Eomes− CD56dim cells may represent developmentally dis-
tinct, liver-derived NK cells, which recently have been described
in mice as Eomes-independent (68). This subset has not been
clearly defined in humans; therefore, further studies are necessary
to determine the nature and origin of the T-bet+Eomes− NK cell
population we have identified in human peripheral blood.
While T-bet and Eomes are best known for their role in cyto-
toxicity and IFNγ production in T-cells and NK cells, mouse
studies indicate that T-bet is also important for the regulation
of B-cell antibody class switching (51, 52) and maintenance of
IgG2a+ memory B-cells (54). We found that T-bet is not signifi-
cantly expressed in transitional/immature and naïve B-cells, but is
detectable in a subset of memory B-cells and is highly expressed in
plasmablasts. These data support a model where T-bet likely is not
required during early peripheral B-cell development and is first
expressed during the germinal center reaction, where it regulates
class switching. As class-switched B-cells mature, T-bet likely plays
a role in regulating other key functions of these cells. For example,
T-bet may regulate homing of effector B-cells to sites of inflamma-
tion, as CXCR3 expression is controlled by T-bet in mouse B-cells
(53). High frequencies of T-bet expression in plasmablasts indicate
the importance of T-bet in these cells; however, mechanistic stud-
ies will be necessary to better understand the functions of T-bet in
post-germinal center B-cells.
In summary, we have described T-bet and Eomes expression in
carefully delineated resting human PBMC subsets and have iden-
tified novel cell populations that express T-bet and/or Eomes in
resting states. Taken together, our findings suggest potential novel
functions for T-bet and Eomes in the context of a number of
immune cell subsets and lay the foundation for future mechanistic
work to define their numerous roles in human immune cells.
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Figure S1 |T-bet and Eomes expression in CD8+ and CD4+ T-cell memory
populations. (A–D) T-bet and Eomes expression in CD8+ T-cells. (A) The
frequency of CD8+ T-cell memory populations within total CD8+ T-cells is shown.
Populations were defined as described in the text using the memory markers
CCR7, CD45RO, and CD27. (B) Box and whisker graphs displaying the frequency
of T-bethi (grey) and T-betlo (white) cells within each CD8+ memory subset. The
box and whisker graphs display 25–75% (box), 10–90% (whisker), and the
median value (line). (C) The frequency of Eomes+ cells within each CD8+
memory subset is shown. (D) Eomes MFI in CD8+ memory subsets is
displayed using box and whisker graphs. (E–H) T-bet and Eomes expression in
CD4+ T-cells. (E) The frequency of CD4+ T-cell memory populations within total
CD4+ T-cells is shown. (B) Box and whisker graphs displaying the frequency of
T-bethi (grey) and T-betlo (white) cells within each CD4+ memory subset. The box
and whisker graphs display 25–75% (box), 10–90% (whisker), and the median
value (line). (C) The frequency of Eomes+ cells within each CD8+ memory
subset is shown. (D) Eomes MFI in CD4+ memory subsets is displayed using
box and whisker graphs. *p < 0.04, ** p < 0.004.
Figure S2 | B-cell subset identification. Our method for identifying B-cell
subpopulations via flow cytometry is depicted. B-cells are selected as CD19+
cells within CD3−CD14−CD16− PBMCs. IgD+ B-cells are separated by CD10
expression into CD10-naïve B-cells (CD19+IgD+CD10−CD27−) and CD10+
transitional/immature B-cells (CD19+IgD+CD10+CD27−). IgD− B-cells are
separated by CD38 expression into CD38hi plasmablasts
(CD19+IgD−CD38hiCD27+) and CD38lo/− memory B-cells (CD19+IgD−CD38lo/−).
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